Selling And Administration Expenses Endring Dato
Adcock Ingram Holdings ZAR 989.77M 27M 2023-06
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Cspc Pharmaceutical CNY 2.45B 237.6M 2023-09
Ecofibre AUD 9.89M 2.34M 2023-06
Gilead Sciences USD 1.38B 233M 2024-03
Kangmei Pharma CNY 199.16M 127.36M 2023-09
Knight Therapeutics CAD 23M 1.01M 2023-09
Laboratorios Farma EUR 54.03M 3.27M 2023-06
Magenta Therapeutics USD 8.72M 3.4M 2023-09
Malin Corporation EUR 2.2M 800K 2023-06
Medical Developments International AUD 22.92M 6.46M 2023-06
Merck USD 2.48B 268M 2024-03
Neuren Pharmaceuticals AUD 3.69M 2.98M 2023-06
Organigram Holdings CAD 18.78M 2.93M 2023-03
Organon & Co USD 422M 116M 2023-12
Pharma Mar EUR 8.89M 2.77M 2023-09
Probiotec AUD 15.11M 1.77M 2023-06
Qiagen NV USD 138.69M 7.26M 2024-03
Sartorius EUR 223.9M 11.8M 2024-03
Sino Biopharmaceutical CNY 6.44B 814.26M 2023-06



Organon & Co Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.